SCIENTURE HOLDINGS, INC. Disposal Group, Including Discontinued Operation, Revenue
SCIENTURE HOLDINGS, INC. (SCNX) reported Disposal Group, Including Discontinued Operation, Revenue of $970.81 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, revenue for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, revenue for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, revenue for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, revenue for the quarter ending 2024-03-31 was $970.81K, a 44.67% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, revenue for fiscal 2024 was $970.81K, a 87.49% decline from fiscal 2023.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, revenue for fiscal 2023 was $7.76M, a 547.71% increase from fiscal 2022.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, revenue for fiscal 2022 was $1.20M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 3 month as first filed | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 9 month as first filed | Disposal Group, Including Discontinued Operation, Revenue 12 month | Disposal Group, Including Discontinued Operation, Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $970.81K 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $970.81K 10-Q · filed 2025-11-12 | $3.29M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $970.81K 10-Q · filed 2025-08-12 | $3.29M derived: sum of 3 quarters · filed 2025-08-12 | $5.08M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $970.81K 10-Q · filed 2025-05-12 | $3.29M derived: sum of 2 quarters · filed 2025-05-12 | $5.08M derived: sum of 3 quarters · filed 2025-05-12 | $6.96M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $4.10M derived: sum of 2 quarters · filed 2025-03-26 | $5.99M derived: sum of 3 quarters · filed 2025-03-26 | $7.76M 10-K · filed 2025-03-26 | $851.75K 10-K · filed 2024-04-22 | ||
| 2023-09-30 | $1.79M 10-Q · filed 2024-11-06 | $124.24K 10-Q · filed 2024-01-16 | $3.67M derived: sum of 2 quarters · filed 2024-11-06 | $5.45M 10-Q · filed 2024-11-06 | $761.31K 10-Q · filed 2024-01-16 | $5.70M derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $1.88M 10-Q · filed 2024-08-09 | $3.66M 10-Q · filed 2024-08-09 | $3.91M derived: sum of 3 quarters · filed 2024-08-09 | $4.26M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $1.75M 10-Q · filed 2024-06-26 | $2.03M derived: sum of 2 quarters · filed 2024-06-26 | $2.37M derived: sum of 3 quarters · filed 2024-06-26 | ||||
| 2022-12-31 | $272.59K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $617.10K derived: sum of 2 quarters · filed 2024-04-22 | $1.20M 10-K · filed 2024-04-22 | ||||
| 2022-09-30 | $344.51K 10-Q · filed 2024-01-16 | $925.51K 10-Q · filed 2024-01-16 | |||||
| 2016-09-30 | $192.45K 10-Q · filed 2017-11-07 | $1.29M derived: sum of 2 quarters · filed 2017-11-07 | $2.50M 10-Q · filed 2017-11-07 | ||||
| 2016-06-30 | $1.10M 10-Q · filed 2017-08-04 | $2.30M 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |